A Trial Investigating the Effect of NN5401 in Subjects With Type 2 Diabetes

NCT01134224 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: insulin degludec/insulin aspart
DRUG: insulin degludec/insulin aspart
DRUG: insulin degludec/insulin aspart
DRUG: biphasic insulin aspart 30
DRUG: biphasic insulin aspart 30
DRUG: biphasic insulin aspart 30

Sponsor

Novo Nordisk A/S